61 arrivals from South Africa test positive for COVID-19 in Netherlands
Further tests are now underway on the travellers who arrived at Amsterdam’s Schiphol Airport to establish if any of them have the new Omicron variant of COVID-19
The Hague: A total of 61 people who arrived in the Netherlands on two flights from South Africa on Friday tested positive for the coronavirus and were in isolation on Saturday as the world anxiously sought to contain a highly transmissible new coronavirus variant.
Further tests are now underway on the travelers who arrived at Amsterdam’s Schiphol Airport to establish if any of them have the new omicron variant of COVID-19 that was first discovered in southern Africa.
The variant’s swift spread among young people in South Africa has alarmed health professionals. In just two weeks, omicron has turned a period of low transmission in the country into one of rapid growth.
Two planes arrived in the Netherlands from Johannesburg and Cape Town shortly after the Dutch government, along with other nations around the world, on Friday imposed a ban on flights from southern African nations following discovery of the new omicron variant.
The Kennermerland local health authority, which is responsible for the testing and isolation operation, said in an update Saturday that the people who tested positive must quarantine for seven days if they have symptoms and five days if they are symptom-free.
The 539 travelers who tested negative were allowed to return home or continue their journeys to other countries. Under government regulations, those who live in the Netherlands and are allowed to return home must self-isolate for at least five days.
Omicron News Updates: Schools across Maharashtra to reopen for all classes from 24 Jan, says Varsha Gaikwad
Omicron News LIVE Updates: The decision comes in the wake of cases rising across the state, 43,697 cases on Wednesday, and ebbing in the city of Mumbai
Omicron News LIVE Updates: Govt panel recommends market approval for Covaxin, Covishield but with conditions
Omicron News LIVE Updates: The recommendations will be sent to the Drugs Controller General of India for final approval. Covishield and Covaxin were granted emergency use authorisation on 3 January, 2021
As per an analysis by a US Centers for Disease Control and Prevention, cough, fatigue, congestion and runny nose are the four most common symptoms of the Omicron variant